HeartWare Shares Rise on Panel Backing of Implantable Pump

HeartWare International Inc. rose the most in more than a year after its implantable pump for heart-transplant candidates gained support from U.S. regulatory advisers who said the device provides dying patients a lifeline.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.